Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the government of India has issued a registration certificate and a permission to import the COVID-19 Vaccine Moderna for restricted use in an emergency situation.
Moderna announces emergency use authorization for its COVID-19 vaccine granted by government of India
June 30, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022